Renaissance Technologies’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.06B | Sell |
1,787,019
-122,240
| -6% | -$60.9M | 1.66% | 1 |
|
|
2025
Q4 | $930M | Sell |
1,909,259
-264,133
| -12% | -$123M | 1.44% | 2 |
|
|
2025
Q3 | $911M | Buy |
2,173,392
+54,300
| +3% | +$18.3M | 1.2% | 4 |
|
|
2025
Q2 | $609M | Buy |
2,119,092
+12,100
| +0.6% | +$3.62M | 0.81% | 12 |
|
|
2025
Q1 | $650M | Buy |
2,106,992
+17,600
| +0.8% | +$6.03M | 0.98% | 6 |
|
|
2024
Q4 | $737M | Sell |
2,089,392
-66,000
| -3% | -$24.3M | 1.09% | 2 |
|
|
2024
Q3 | $772M | Sell |
2,155,392
-19,300
| -0.9% | -$6.52M | 1.16% | 3 |
|
|
2024
Q2 | $693M | Buy |
2,174,692
+22,978
| +1% | +$6.08M | 1.18% | 5 |
|
|
2024
Q1 | $494M | Sell |
2,151,714
-18,500
| -0.9% | -$4.17M | 0.78% | 10 |
|
|
2023
Q4 | $477M | Sell |
2,170,214
-80,294
| -4% | -$18.5M | 0.74% | 11 |
|
|
2023
Q3 | $508M | Buy |
2,250,508
+63,294
| +3% | +$14.6M | 0.87% | 10 |
|
|
2023
Q2 | $483M | Sell |
2,187,214
-40,200
| -2% | -$8.9M | 0.7% | 13 |
|
|
2023
Q1 | $499M | Sell |
2,227,414
-117,078
| -5% | -$28.9M | 0.66% | 12 |
|
|
2022
Q4 | $652M | Sell |
2,344,492
-205,722
| -8% | -$51.9M | 0.89% | 6 |
|
|
2022
Q3 | $534M | Sell |
2,550,214
-243,377
| -9% | -$54.4M | 0.76% | 11 |
|
|
2022
Q2 | $658M | Buy |
2,793,591
+28,378
| +1% | +$5.77M | 0.78% | 11 |
|
|
2022
Q1 | $496M | Sell |
2,765,213
-151,978
| -5% | -$29M | 0.58% | 23 |
|
|
2021
Q4 | $630M | Sell |
2,917,191
-111,400
| -4% | -$21.9M | 0.78% | 9 |
|
|
2021
Q3 | $559M | Sell |
3,028,591
-81,600
| -3% | -$16.1M | 0.72% | 16 |
|
|
2021
Q2 | $558M | Sell |
3,110,191
-97,400
| -3% | -$18.6M | 0.7% | 17 |
|
|
2021
Q1 | $537M | Sell |
3,207,591
-399,700
| -11% | -$66.6M | 0.67% | 16 |
|
|
2020
Q4 | $548M | Sell |
3,607,291
-101,727
| -3% | -$13.3M | 0.59% | 22 |
|
|
2020
Q3 | $375M | Sell |
3,709,018
-17,800
| -0.5% | -$1.95M | 0.37% | 50 |
|
|
2020
Q2 | $451M | Buy |
3,726,818
+136,595
| +4% | +$15.4M | 0.39% | 47 |
|
|
2020
Q1 | $340M | Buy |
3,590,223
+45,790
| +1% | +$4.35M | 0.33% | 55 |
|
|
2019
Q4 | $312M | Buy |
3,544,433
+332,155
| +10% | +$29.2M | 0.24% | 79 |
|
|
2019
Q3 | $256M | Buy |
3,212,278
+171,300
| +6% | +$13.8M | 0.22% | 96 |
|
|
2019
Q2 | $237M | Buy |
3,040,978
+799,200
| +36% | +$74.7M | 0.21% | 100 |
|
|
2019
Q1 | $263M | Buy |
2,241,778
+45,000
| +2% | +$5.24M | 0.24% | 82 |
|
|
2018
Q4 | $239M | Buy |
2,196,778
+252,700
| +13% | +$29.3M | 0.26% | 70 |
|
|
2018
Q3 | $249M | Buy |
1,944,078
+387,878
| +25% | +$48M | 0.26% | 69 |
|
|
2018
Q2 | $176M | Buy |
1,556,200
+22,322
| +1% | +$2.45M | 0.19% | 98 |
|
|
2018
Q1 | $172M | Buy |
1,533,878
+71,500
| +5% | +$9.08M | 0.19% | 97 |
|
|
2017
Q4 | $216M | Buy |
1,462,378
+189,378
| +15% | +$24.1M | 0.24% | 67 |
|
|
2017
Q3 | $149M | Buy |
1,273,000
+435,400
| +52% | +$55.6M | 0.18% | 111 |
|
|
2017
Q2 | $109M | Buy |
837,600
+331,400
| +65% | +$41.3M | 0.14% | 155 |
|
|
2017
Q1 | $68.5M | Buy |
506,200
+85,000
| +20% | +$12.9M | 0.1% | 248 |
|
|
2016
Q4 | $60.4M | Buy |
421,200
+31,100
| +8% | +$3.97M | 0.1% | 256 |
|
|
2016
Q3 | $46.1M | Sell |
390,100
-14,200
| -4% | -$1.71M | 0.08% | 302 |
|
|
2016
Q2 | $42.8M | Sell |
404,300
-70,278
| -15% | -$7.84M | 0.08% | 312 |
|
|
2016
Q1 | $52.9M | Sell |
474,578
-77,500
| -14% | -$9.81M | 0.1% | 224 |
|
|
2015
Q4 | $86.5M | Sell |
552,078
-314,700
| -36% | -$45.8M | 0.19% | 85 |
|
|
2015
Q3 | $114M | Buy |
866,778
+55,200
| +7% | +$8.85M | 0.27% | 49 |
|
|
2015
Q2 | $141M | Buy |
811,578
+365,078
| +82% | +$65.7M | 0.32% | 37 |
|
|
2015
Q1 | $77M | Buy |
446,500
+261,262
| +141% | +$39.8M | 0.16% | 113 |
|
|
2014
Q4 | $24M | Buy |
185,238
+182,860
| +7,690% | +$23.6M | 0.06% | 415 |
|
|
2014
Q3 | $306K | Sell |
2,378
-250,100
| -99% | -$25.8M | ﹤0.01% | 2470 |
|
|
2014
Q2 | $22.3M | Sell |
252,478
-35,462
| -12% | -$3.41M | 0.05% | 422 |
|
|
2014
Q1 | $27.1M | Buy |
287,940
+63,662
| +28% | +$6.51M | 0.06% | 369 |
|
|
2013
Q4 | $25.4M | Sell |
224,278
-216,500
| -49% | -$19.5M | 0.06% | 387 |
|
|
2013
Q3 | $34.8M | Sell |
440,778
-149,600
| -25% | -$10.9M | 0.08% | 275 |
|
|
2013
Q2 | $38.9M | Buy |
+590,378
| New | +$38M | 0.1% | 235 |
|
Other funds holding UTHR
ACA
VPM
VCM
Renaissance Technologies's UTHR Position: Q1 2026 in Review
Renaissance Technologies reduced its United Therapeutics (UTHR) stake by 6.4% in Q1 2026, selling an estimated $60.9M and leaving 1,787,019 shares worth $1.06B. The position accounts for 1.66% of the portfolio, ranked #1.
Renaissance Technologies first reported a position in UTHR in Q2 2013 and has held it in 52 quarters since. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.
- Renaissance Technologies held 1,787,019 shares of United Therapeutics worth $1.06B as of Q1 2026.
- Renaissance Technologies sold 122,240 United Therapeutics shares in Q1 2026, an estimated $60.9M.
- United Therapeutics made up 1.66% of Renaissance Technologies's portfolio in Q1 2026, its #1 holding.
- Renaissance Technologies first reported a position in United Therapeutics in Q2 2013 and has held it in 52 quarters since.
- 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.